Journal
ENEURO
Volume 4, Issue 6, Pages -Publisher
SOC NEUROSCIENCE
DOI: 10.1523/ENEURO.0167-17.2017
Keywords
alpha-synuclein; calcium; mitochondria; dopamine; Parkinson's disease; neurodegeneration; MPP+; MPTP
Categories
Funding
- National Institute of Neurological Disorders and Stroke at the National Institutes of Health [NS075222, NS047085, T32 GM007367]
- Parkinson's Disease Foundation
- JPB Foundations
Ask authors/readers for more resources
Parkinson's disease (PD) is a debilitating neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra (SN). Although mitochondrial dysfunction and dysregulated alpha-synuclein (aSyn) expression are postulated to play a role in PD pathogenesis, it is still debated why neurons of the SN are targeted while neighboring dopaminergic neurons of the ventral tegmental area (VTA) are spared. Using electrochemical and imaging approaches, we investigated metabolic changes in cultured primary mouse midbrain dopaminergic neurons exposed to a parkinsonian neurotoxin, 1-methyl-4-phenylpyridinium (MPP+). We demonstrate that the higher level of neurotoxicity in SN than VTA neurons was due to SN neuron-specific toxin-induced increase in cytosolic dopamine (DA) and Ca2+, followed by an elevation of mitochondrial Ca2(+), activation of nitric oxide synthase (NOS), and mitochondrial oxidation. The increase in cytosolic Ca2+ was not caused by MPP+-induced oxidative stress, but rather depended on the activity of both L-type calcium channels and aSyn expression, suggesting that these two established pathogenic factors in PD act in concert.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available